Beth Weinberg

Generell Rådgivare på APNIMED, INC.

Health Technology

Consumer Services

Profil

Beth Weinberg is currently Chief Regulatory & Safety Officer at Apnimed, Inc. Former positions include Vice President & Head-Regulatory at Angion Biomedica Corp., VP, Head-Regulatory Affairs & Quality at Metavant Sciences, Inc., and Senior Vice President-Regulatory Affairs at CARA Therapeutics, Inc. from 2022 to 2024.
Education includes undergraduate studies at Butler University and Bradley University.

Aktiva positioner av Beth Weinberg

Företag	Position	Start
APNIMED, INC.	Generell Rådgivare	-

Alla aktiva positioner av Beth Weinberg

Tidigare kända positioner av Beth Weinberg

Företag	Position	Slut
CARA THERAPEUTICS, INC.	Generell Rådgivare	2024-07-01
ANGN BIOM	Generell Rådgivare	-
Metavant Sciences, Inc. Metavant Sciences, Inc. Part of Roivant Sciences Ltd., Metavant Sciences, Inc. is a biotechnology company founded in 2014 with the goal of improving the lives of patients by accelerating the development and commercialization of medicines that matter. The company builds nimble subsidiaries called "Vants" to develop and commercialize its medicines and technologies. Metavant Sciences, Inc. has a diverse pipeline of investigational drugs across its family of companies, including Immunovant, Dermavant, and Priovant. Immunovant focuses on developing potentially transformative therapies for autoimmune diseases, while Priovant is developing targeted therapies for severe autoimmune diseases. The company is based in New York.	Generell Rådgivare	-

Se detaljerna i Beth Weinbergs erfarenhet

Beth Weinbergs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Beth Weinbergs erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	6
CARA Therapeutics, Inc. CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed	Health Technology
Butler University Butler University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bradley University Bradley University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Angion Biomedica Corp. Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products	Health Technology
Apnimed, Inc. Apnimed, Inc. BiotechnologyHealth Technology Engages in developing and commercializing of proprietary therapeutics for sleep apnea & breathing diseases	Health Technology
Metavant Sciences, Inc. Metavant Sciences, Inc. Part of Roivant Sciences Ltd., Metavant Sciences, Inc. is a biotechnology company founded in 2014 with the goal of improving the lives of patients by accelerating the development and commercialization of medicines that matter. The company builds nimble subsidiaries called "Vants" to develop and commercialize its medicines and technologies. Metavant Sciences, Inc. has a diverse pipeline of investigational drugs across its family of companies, including Immunovant, Dermavant, and Priovant. Immunovant focuses on developing potentially transformative therapies for autoimmune diseases, while Priovant is developing targeted therapies for severe autoimmune diseases. The company is based in New York.